{
    "name": "clindamycin topical",
    "comment": "Rx",
    "other_names": [
        "Cleocin T",
        "Clindagel",
        "Clindacin P",
        "ClindaReach",
        "ClindaDerm",
        "ClindaMax",
        "Clindets",
        "Evoclin"
    ],
    "classes": [
        "Acne Agents",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/cleocin-t-clindagel-clindamycin-topical-343467",
    "pregnancy": {
        "common": [
            "In clinical trials with pregnant women, systemic administration of clindamycin during second and third trimesters has not been associated with increased frequency of congenital abnormalities; there are no adequate studies in pregnant women during first trimester of pregnancy; clindamycin should be used during first trimester of pregnancy only if clearly needed"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether clindamycin is excreted in human milk following therapy; however, orally and parenterally administered clindamycin has been reported to appear in breast milk; clindamycin has potential to cause adverse effects on breastfed infant's gastrointestinal flora; if oral or intravenous clindamycin is required by a nursing mother, it is not a reason to discontinue breastfeeding, but an alternate drug may be preferred; monitor infant for possible adverse effects on gastrointestinal flora, such as diarrhea, candidiasis (thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis",
            "Developmental and health benefits of breastfeeding should be considered along with mother's clinical need for clindamycin and any potential adverse effects on breastfed child from clindamycin or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Pseudomembranous colitis reported with nearly all antibacterial agents, including clindamycin, and may range in severity from mild to life-threatening; orally and parenterally administered clindamycin associated with severe colitis which may end fatally; diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) reported with use of orally and parenterally administered clindamycin, as well as with topical (dermal and vaginal) formulations of clindamycin; important to consider this diagnosis in patients who present with diarrhea subsequent to administration of clindamycin, even when administered by vaginal route, because approximately 5% of clindamycin dose is systemically absorbed from vagina"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to clindamycin or lincomycin or to any of its components",
                "History of regional enteritis, ulcerative colitis, or antibiotic-associated colitis (including pseudomembranous colitis)",
                "Not indicated for inflammatory acne"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Systemic absorption of clindamycin has been demonstrated following topical use; discontinue immediately if significant diarrhea occurs",
                "May cause irritation, especially when used with concomitant topical acne therapy, including with peeling, desquamating, or abrasive agents",
                "Should be used with caution in atopic individuals",
                "For external use only; avoid contact with eyes and mucous membranes",
                "If applied to chest by nursing mothers, care should be taken to avoid accidental ingestion by infant"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Application site pain",
            "percent": null
        },
        {
            "name": "erythema",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "Gram",
            "percent": null
        },
        {
            "name": "negative folliculitis",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Seborrhea",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Abdominal discomfort",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Colitis",
            "percent": null
        },
        {
            "name": "including pseudomembranous colitis",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Hemorrhagic diarrhea",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        }
    ]
}